Cystic fibrosis (CF)-related diabetes (CFRD) is present in upwards of 20% of adolescents and 40-50% of adults with CF and is associated with significant glycemic variability, poor glycemic control, and unpredictable hypoglycemia. CFRD is increasing in prevalence as new disease-modifying therapies have led to a significant increase in life expectancy in those with CF. While […]